Cost-effectiveness and Cost-utility of the Adherence Improving Self-management Strategy in Human Immunodeficiency Virus Care: A Trial-based Economic Evaluation | Zendy

Ben Wijnen | Zendy; E. Oberjé | Zendy; Silvia M. A. A. Evers | Zendy; Jan M. Prins | Zendy; Hans-Erik Nobel | Zendy; Cees van Nieuwkoop | Zendy; Jan A. Veenstra | Zendy; F J J Pijnappel | Zendy; Frank P. Kroon | Zendy; Laura van Zonneveld | Zendy; A. G. W. van Hulzen | Zendy; Marjolein van Broekhuizen | Zendy; Marijn de Bruin | Zendy

Open Access

Cost-effectiveness and Cost-utility of the Adherence Improving Self-management Strategy in Human Immunodeficiency Virus Care: A Trial-based Economic Evaluation

Author(s) -

Ben Wijnen,

E. Oberjé,

Silvia M. A. A. Evers,

Jan M. Prins,

Hans-Erik Nobel,

Cees van Nieuwkoop,

Jan A. Veenstra,

F J J Pijnappel,

Frank P. Kroon,

Laura van Zonneveld,

A. G. W. van Hulzen,

Marjolein van Broekhuizen,

Marijn de Bruin

Publication year - 2018

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciy553

Subject(s) - medicine , human immunodeficiency virus (hiv) , intensive care medicine , cost effectiveness , risk analysis (engineering) , immunology

Several promising human immunodeficiency virus (HIV) treatment adherence interventions have been identified, but data about their cost-effectiveness are lacking. This study examines the trial-based cost-effectiveness and cost-utility of the proven-effective Adherence Improving Self-Management Strategy (AIMS), from a societal perspective, with a 15-month time horizon.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research